Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
Wagner T, Toft BG, Lauritsen J, Bandak M, Christensen IJ, Engvad B, Kreiberg M, Agerbæk M, Dysager L, Carus A, Rosenvilde JJ, Berney D, Daugaard G. Wagner T, et al. Among authors: kreiberg m. Eur J Cancer. 2024 May;202:114025. doi: 10.1016/j.ejca.2024.114025. Epub 2024 Mar 17. Eur J Cancer. 2024. PMID: 38531266 Free article.
Insulin-like Factor 3, Basal and Human Chorionic Gonadotropin-Stimulated Testosterone as Biomarkers to Predict the Effect of Testosterone Replacement in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency.
Medici C, Jørgensen N, Juul A, Albrethsen J, Kreiberg M, Lauritsen J, Wagner T, Rosenvilde J, Daugaard G, Bandak M. Medici C, et al. Among authors: kreiberg m. Clin Genitourin Cancer. 2024 Feb;22(1):e106-e112.e4. doi: 10.1016/j.clgc.2023.08.005. Epub 2023 Aug 16. Clin Genitourin Cancer. 2024. PMID: 37673783 Free article.
Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.
Jørgensen PL, Kreiberg M, Jørgensen N, Juul A, Oturai PS, Dehlendorff C, Lauritsen J, Wagner T, Rosenvilde J, Daugaard G, Medici CR, Jørgensen NR, Bandak M. Jørgensen PL, et al. Among authors: kreiberg m. Acta Oncol. 2023 Jul;62(7):689-695. doi: 10.1080/0284186X.2023.2207218. Epub 2023 May 7. Acta Oncol. 2023. PMID: 37151105 Clinical Trial.
A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer.
Wagner T, Lauritsen J, Bandak M, Rasmussen LA, Bakker J, Hovaldt HB, Larsson H, Christensen IJ, Toft BG, Agerbæk M, Dysager L, Kreiberg M, Rosenvilde JJ, Engvad B, Berney DM, Daugaard G. Wagner T, et al. Among authors: kreiberg m. Clin Epidemiol. 2023 Apr 5;15:447-457. doi: 10.2147/CLEP.S401737. eCollection 2023. Clin Epidemiol. 2023. PMID: 37041861 Free PMC article.
A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
Kreiberg M, Jørgensen N, Juul A, Lauritsen J, Oturai P, Helge JW, Christensen JF, Aksglaede L, Schauer T, Wagner T, Rosenvilde J, Grunwald E, Dehlendorff C, Daugaard G, Bandak M. Kreiberg M, et al. Clin Genitourin Cancer. 2022 Oct;20(5):404-414. doi: 10.1016/j.clgc.2022.04.017. Epub 2022 May 2. Clin Genitourin Cancer. 2022. PMID: 35701334 Free article. Clinical Trial.
Effect of Testosterone Replacement Therapy on Quality of Life and Sexual Function in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency: Results From a Randomized Double-blind Trial.
Højer EG, Kreiberg M, Dehlendorff C, Jørgensen N, Juul A, Lauritsen J, Wagner T, Rosenvilde J, Daugaard G, Bandak M. Højer EG, et al. Among authors: kreiberg m. Clin Genitourin Cancer. 2022 Aug;20(4):334-343. doi: 10.1016/j.clgc.2022.03.012. Epub 2022 Apr 1. Clin Genitourin Cancer. 2022. PMID: 35514022 Free article. Clinical Trial.
30 results